Overview

Cethrin in Acute Cervical Spinal Cord Injury

Status:
Withdrawn

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This is a multicenter, randomized, double-blind, placebo-controlled Phase IIb/III study designed to evaluate the efficacy and safety of Cethrin as a treatment for acute cervical spinal cord injury. During the trial, high and low doses of Cethrin will be compared with placebo.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

BioAxone BioSciences, Inc.

Treatments:

Fibrin Tissue Adhesive